Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

1.

Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.

Erzegovesi S, Guglielmo E, Siliprandi F, Bellodi L.

Eur Neuropsychopharmacol. 2005 Jan;15(1):69-74.

PMID:
15572275
[PubMed - indexed for MEDLINE]
2.

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.

Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF.

Mol Psychiatry. 2006 Jul;11(7):622-32. Epub 2006 Apr 4. Review. Erratum in: Mol Psychiatry. 2006 Aug;11(8):795.

PMID:
16585942
[PubMed - indexed for MEDLINE]
3.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
4.

[Efficacy of antipsychotic augmentation therapy in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomised, placebo-controlled trials].

Dold M, Aigner M, Lanzenberger R, Kasper S.

Fortschr Neurol Psychiatr. 2011 Aug;79(8):453-66. doi: 10.1055/s-0031-1273397. Epub 2011 Aug 1. Review. German.

PMID:
21809258
[PubMed - indexed for MEDLINE]
5.

Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions.

Goodman WK, Ward H, Kablinger A, Murphy T.

J Clin Psychiatry. 1997;58 Suppl 5:32-49. Review.

PMID:
9184625
[PubMed - indexed for MEDLINE]
6.

A review of pharmacologic treatments for obsessive-compulsive disorder.

Kaplan A, Hollander E.

Psychiatr Serv. 2003 Aug;54(8):1111-8. Review.

PMID:
12883138
[PubMed - indexed for MEDLINE]
7.

Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials.

Dold M, Aigner M, Lanzenberger R, Kasper S.

Int J Neuropsychopharmacol. 2013 Apr;16(3):557-74. doi: 10.1017/S1461145712000740. Epub 2012 Aug 29. Review.

PMID:
22932229
[PubMed - indexed for MEDLINE]
8.

[Prescription of olanzapine in children and adolescent psychiatric patients].

Frémaux T, Reymann JM, Chevreuil C, Bentué-Ferrer D.

Encephale. 2007 Mar-Apr;33(2):188-96. Review. French.

PMID:
17675914
[PubMed - indexed for MEDLINE]
9.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
[PubMed - indexed for MEDLINE]
10.

Use of atypical antipsychotics in refractory depression and anxiety.

Nemeroff CB.

J Clin Psychiatry. 2005;66 Suppl 8:13-21. Review.

PMID:
16336032
[PubMed - indexed for MEDLINE]
11.

Efficacy of treatments for patients with obsessive-compulsive disorder: a systematic review.

Choi YJ.

J Am Acad Nurse Pract. 2009 Apr;21(4):207-13. doi: 10.1111/j.1745-7599.2009.00408.x. Review.

PMID:
19366379
[PubMed - indexed for MEDLINE]
12.

Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: a meta-analysis of the randomized controlled trials.

Skapinakis P, Papatheodorou T, Mavreas V.

Eur Neuropsychopharmacol. 2007 Jan 15;17(2):79-93. Epub 2006 Aug 10. Review.

PMID:
16904298
[PubMed - indexed for MEDLINE]
13.

Serotonergic antidepressants and their efficacy in obsessive compulsive disorder.

Dominguez RA.

J Clin Psychiatry. 1992 Oct;53 Suppl:56-9. Review.

PMID:
1429485
[PubMed - indexed for MEDLINE]
14.

Obsessive-compulsive symptoms associated with clozapine and risperidone treatment: three case reports and review of the literature.

Ke CL, Yen CF, Chen CC, Yang SJ, Chung W, Yang MJ.

Kaohsiung J Med Sci. 2004 Jun;20(6):295-301. Review.

PMID:
15253471
[PubMed - indexed for MEDLINE]
15.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
[PubMed - indexed for MEDLINE]
16.

Fluvoxamine in the treatment of obsessive compulsive disorder.

Montgomery SA, Manceaux A.

Int Clin Psychopharmacol. 1992 Jun;7 Suppl 1:5-9. Review.

PMID:
1355499
[PubMed - indexed for MEDLINE]
17.

Management of treatment-refractory obsessive compulsive disorder patients.

Dominguez RA, Mestre SM.

J Clin Psychiatry. 1994 Oct;55 Suppl:86-92. Review.

PMID:
7961537
[PubMed - indexed for MEDLINE]
18.

Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder.

McDougle CJ, Goodman WK, Price LH.

J Clin Psychiatry. 1994 Mar;55 Suppl:24-31. Review.

PMID:
7521326
[PubMed - indexed for MEDLINE]
19.

Fluvoxamine: a review of its therapeutic potential in the management of anxiety disorders in children and adolescents.

Cheer SM, Figgitt DP.

Paediatr Drugs. 2001;3(10):763-81. Review. Erratum in: Paediatr Drugs 2001;3(11):801.

PMID:
11706925
[PubMed - indexed for MEDLINE]
20.

Do antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms? A systematic review.

Sareen J, Kirshner A, Lander M, Kjernisted KD, Eleff MK, Reiss JP.

J Affect Disord. 2004 Oct 15;82(2):167-74. Review.

PMID:
15488245
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk